PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
EBS vs. PLTK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EBS and PLTK is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

EBS vs. PLTK

Last updated May 31, 2025

Compare and contrast key facts about Emergent BioSolutions Inc. (EBS) and Playtika Holding Corp. (PLTK).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EBS or PLTK.

Performance

EBS vs. PLTK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Emergent BioSolutions Inc. (EBS) and Playtika Holding Corp. (PLTK). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

EBS:

0.20

PLTK:

-0.93

Sortino Ratio

EBS:

1.34

PLTK:

-1.31

Omega Ratio

EBS:

1.18

PLTK:

0.83

Calmar Ratio

EBS:

0.35

PLTK:

-0.47

Martin Ratio

EBS:

0.77

PLTK:

-1.69

Ulcer Index

EBS:

43.83%

PLTK:

24.51%

Daily Std Dev

EBS:

123.15%

PLTK:

45.97%

Max Drawdown

EBS:

-98.89%

PLTK:

-87.38%

Current Drawdown

EBS:

-95.32%

PLTK:

-85.08%

Fundamentals

Market Cap

EBS:

$352.81M

PLTK:

$1.78B

EPS

EBS:

-$2.56

PLTK:

$0.38

PS Ratio

EBS:

0.37

PLTK:

0.68

PB Ratio

EBS:

0.63

PLTK:

0.00

Total Revenue (TTM)

EBS:

$960.00M

PLTK:

$2.60B

Gross Profit (TTM)

EBS:

$303.40M

PLTK:

$1.89B

EBITDA (TTM)

EBS:

$106.30M

PLTK:

$513.60M

Returns By Period

In the year-to-date period, EBS achieves a -33.89% return, which is significantly lower than PLTK's -30.14% return.

EBS

YTD

-33.89%

1M

18.35%

6M

-37.55%

1Y

24.17%

3Y*

-42.34%

5Y*

-40.32%

10Y*

-13.82%

PLTK

YTD

-30.14%

1M

-10.06%

6M

-41.58%

1Y

-42.44%

3Y*

-29.84%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Emergent BioSolutions Inc.

Playtika Holding Corp.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

EBS vs. PLTK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
EBS
The Risk-Adjusted Performance Rank of EBS is 6767
Overall Rank
The Sharpe Ratio Rank of EBS is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of EBS is 7373
Sortino Ratio Rank
The Omega Ratio Rank of EBS is 7373
Omega Ratio Rank
The Calmar Ratio Rank of EBS is 6868
Calmar Ratio Rank
The Martin Ratio Rank of EBS is 6161
Martin Ratio Rank
PLTK
The Risk-Adjusted Performance Rank of PLTK is 88
Overall Rank
The Sharpe Ratio Rank of PLTK is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of PLTK is 77
Sortino Ratio Rank
The Omega Ratio Rank of PLTK is 88
Omega Ratio Rank
The Calmar Ratio Rank of PLTK is 2020
Calmar Ratio Rank
The Martin Ratio Rank of PLTK is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EBS vs. PLTK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Emergent BioSolutions Inc. (EBS) and Playtika Holding Corp. (PLTK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EBS Sharpe Ratio is 0.20, which is higher than the PLTK Sharpe Ratio of -0.93. The chart below compares the historical Sharpe Ratios of EBS and PLTK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

EBS vs. PLTK - Dividend Comparison

EBS has not paid dividends to shareholders, while PLTK's dividend yield for the trailing twelve months is around 8.44%.

TTM202420232022202120202019201820172016
EBS
Emergent BioSolutions Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.65%
PLTK
Playtika Holding Corp.		8.44%5.76%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

EBS vs. PLTK - Drawdown Comparison

The maximum EBS drawdown since its inception was -98.89%, which is greater than PLTK's maximum drawdown of -87.38%. Use the drawdown chart below to compare losses from any high point for EBS and PLTK.

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

EBS vs. PLTK - Volatility Comparison

Emergent BioSolutions Inc. (EBS) has a higher volatility of 40.84% compared to Playtika Holding Corp. (PLTK) at 15.45%. This indicates that EBS's price experiences larger fluctuations and is considered to be riskier than PLTK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

EBS vs. PLTK - Financials Comparison

This section allows you to compare key financial metrics between Emergent BioSolutions Inc. and Playtika Holding Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

200.00M300.00M400.00M500.00M600.00M700.00M20212022202320242025
222.20M
706.00M
(EBS) Total Revenue
(PLTK) Total Revenue
Values in USD except per share items

EBS vs. PLTK - Profitability Comparison

The chart below illustrates the profitability comparison between Emergent BioSolutions Inc. and Playtika Holding Corp. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.
Gross Margin
Operating Margin
Net Margin
Quarterly
Annual
-20.0%0.0%20.0%40.0%60.0%80.0%20212022202320242025
60.2%
72.0%
(EBS) Gross Margin
(PLTK) Gross Margin
EBS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported a gross profit of 133.70M and revenue of 222.20M. Therefore, the gross margin over that period was 60.2%.

PLTK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Playtika Holding Corp. reported a gross profit of 508.60M and revenue of 706.00M. Therefore, the gross margin over that period was 72.0%.

EBS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported an operating income of 49.90M and revenue of 222.20M, resulting in an operating margin of 22.5%.

PLTK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Playtika Holding Corp. reported an operating income of 67.80M and revenue of 706.00M, resulting in an operating margin of 9.6%.

EBS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Emergent BioSolutions Inc. reported a net income of 68.00M and revenue of 222.20M, resulting in a net margin of 30.6%.

PLTK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Playtika Holding Corp. reported a net income of 30.60M and revenue of 706.00M, resulting in a net margin of 4.3%.